The wild-type baculovirus Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) infects a range of mammalian cell types in vitro but does not replicate in these cells. The current study investigated the in vivo effect of AcMNPV in the mouse model of liver cirrhosis induced by the mutagen dimethylnitrosamine. Intraperitoneal injection of AcMNPV induced an immune response. The baculovirus was taken up by the liver and spleen where it suppressed liver injury and fibrosis through the induction of interferons. This study presents the first evidence of the feasibility of using baculovirus to treat liver cirrhosis. Gene Therapy (2008) 15, 990-997;
Introduction
Chronic infection by the hepatitis C virus (HCV) is a major cause of liver cirrhosis (LC) in Japan and some southern European countries, including Italy and Spain, and affects 43% of the population worldwide. 1 Infected individuals are a reservoir for new infections, and are at risk of developing LC and hepatocellular carcinoma. Consequently, HCV infection is the foremost reason for performing liver transplants. 2 Antiviral therapy consisting of peginterferon alfa-2a/ribavirin leads to a sustained response in only half of all patients infected with HCV genotypes 1 and 4, 3, 4 resulting in the need to develop new antiviral therapies. In addition, the emergence of drug resistance in RNA virus infections emphasizes the requirement for multiple drug targets to limit viral escape.
The main characteristic of LC is fibrosis. The normal liver equilibrium of collagen synthesis and decomposition by liver cell proteases is well balanced. In damaged cells, collagen is secreted to form persistent scars, and excess secreted collagen is degraded. However, this balance is disrupted by chronic hepatic damage such as fibrosis, a result of wound healing after repeated hepatic injury and impaired degradation of excess collagen. 5 Following liver damage, inflammatory lymphatic cells infiltrate the liver parenchyma, and many hepatic cells undergo apoptosis, leading to the activation of Kupffer cells. Hepatic stellate cells (HSCs) proliferate, become activated and secrete large amounts of extracellular matrices (such as collagen, fibronectin and elastin). Sinusoidal endothelial cells lose their fenestrations, and continual cardiac contraction of HSCs increases the blood-flow resistance in the liver sinusoid. The reduction of secreted collagen to normal levels is therefore likely to limit the progression of liver cancer and may lead to a cure for hepatitis.
We recently reported that the activation of natural immunity in mice by intranasal preadministration of baculovirus has a life-prolonging effect against lethal doses of influenza virus. 6 Baculovirus also stimulates Toll-like receptor 9, which plays an important role in the activation of innate immunity. 7 Baculovirus infection activates tumor necrosis factor-a, interleukin (IL)-1a and IL-1b expression in primary hepatocyte cultures, 8 probably due to the presence of small numbers of Kupffer cells in the culture population, 9 while adenoviral vector expression of interferon (IFN)-a and IFN-g in the liver of rats with hepatic fibrosis improves the symptoms of hepatic fibrosis. 10, 11 In the present study, we used a mouse model of hepatic fibrosis to investigate the therapeutic efficacy of the baculovirus Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) on immune response induction, and the suppression of liver injury and fibrosis in vivo. The results of the present study provide the first evidence of the feasibility of using baculovirus to treat LC.
Results

Establishment of a mouse hepatic fibrosis model
The mutagen dimethylnitrosamine (DMN) causes liver function disorders and cirrhosis. It is widely used in experimental animals, such as rats and mice 10, [12] [13] [14] to create a low-mortality and reproducible model of liver fibrosis [15] [16] [17] [18] that is characterized in the early stages by centrilobular injury, followed by perivenular fibrosis and the formation of septa with the development of micronodular cirrhosis after 3 weeks of treatment. In this model, collagen accumulation is preceded by hepatic stem cell proliferation, which accumulates where fibrous septa will later appear, 19 and is associated with increased mRNA expression of types I, III and IV procollagen. 20 In the present study, we observed that the body weight of DMN-treated mice was significantly reduced compared with controls after 3 weeks of treatment in all of the groups. To quantitatively assess liver fibrosis, we measured the serum levels of alanine transaminase (ALT) and aspartate transaminase (AST), and found that they increased in all of the DMN-administered groups, indicating liver damage (Figure 1a) . DMN treatment also increased overall collagen synthesis (Figure 1b) , and led to the collapse of parenchymal cells and the formation of regenerative nodules separated by extensive fibrous septa, which are similar to the characteristic pathologic changes observed in human LC (Figures 1c and d) .
Effects of intraperitoneal baculovirus injection in mice with DMN-induced LC
To examine the efficiency of baculovirus-mediated immunotherapy, mice with DMN-induced LC were intraperitoneally injected with baculovirus. Although complement-resistant baculovirus can express inserted foreign genes in vivo, 21, 22 it is not known whether wildtype baculovirus AcMNPV that is not expressed in vivo is capable of infecting mammalian tissues. The tissue tropism of AcMNPV was therefore examined by PCR analysis of DNA isolated from 10 7 plaque-forming unit The levels of collagen in the liver were confirmed by colorimetry. Saline administration did not affect the extent of DMN-induced collagen accumulation, which remained high (Figure 4a ). In contrast, administration of baculovirus significantly reduced the amount of accumulated collagen compared to the saline group, although there were no significant differences between different concentrations of baculovirus. We also used reverse transcription (RT)-PCR to examine the hepatic expression of AcMNPV-vp39 and revealed no significant differences between mice infected with different concentrations of AcMNPV (10 3 , 10 5 and 10 7 PFU; Figure 4b ). This may be due to the fact that vp39 gene expression, which is associated with the instability of baculoviral DNA in mice, is independent of the viral dose. These results indicate that baculovirus administration alleviated hepatic tissue damage by decreasing the accumulation of collagen.
To quantitatively assess the extent of liver fibrosis, we measured the serum levels of AST and ALT. Baculovirus-administered mice had significantly lower levels of transaminases than DMN-or saline-injected mice (Figures 4c and d) . As DMN-induced hepatic transaminase elevation does not regress spontaneously in the mouse LC model, [23] [24] [25] our observation suggested that baculovirus can rescue mice from DMN-induced hepatic damage and improve LC histopathology.
The expression of matrix metalloproteases (MMPs) and tissue inhibitors of metalloproteinases (TIMP), which is related to matrix degradation during liver fibrosis, was then analyzed by RT-PCR ( Figure 5 ). Interstitial collagenase (MMP-13) is an essential enzyme for collagenolysis in liver fibrosis, and its expression increases at the peak of fibrosis development and drops rapidly during the recovery periods.
23,24 MMP-2, which is stimulated by transforming growth factor-b (TGF-b), is necessary for the proliferation and infiltration of HSCs during the process of fibrosis formation. [25] [26] [27] [28] [29] Increased TIMP-1 expression promotes liver fibrosis progression by preventing the degradation of secreted collagens, and TIMP-1 expression decreases during the recovery phase. 30 In this study, MMP-13, MMP-2 and TIMP-1 expression levels were downregulated in mouse livers treated with baculovirus compared with saline-injected cirrhotic livers ( Figure 5 ).
IFN induction
IFN-g has previously been shown to have immunomodulatory effects, 31 and decreases collagen synthesis in human chondrocytes, fetal rat bone and human dermal fibroblasts. [32] [33] [34] [35] In vivo models of enhanced collagen synthesis have also revealed that IFN-g reduces the collagen accumulation associated with foreign bodies, skin wound healing and bleomycin-induced lung AcMNPV-mediated IFN alleviates LC in a murine model Y Nishibe et al fibrosis. [36] [37] [38] Further, in liver fibrosis induced by Schistosoma mansoni infection, IFN-g significantly reduces collagen accumulation, and type I and III procollagen mRNA levels. Hepatocyte growth factor (HGF) is one of a potent growth factors involved in liver regeneration and has a strong effect on epithelial and nonepithelial cells. [39] [40] [41] [42] On the other hand, it is reported that the overexpression of TGF-b plays a pivotal role in the progression of fibrosis. 43, 44 In the present study, hepatic expression levels of IFNs, HGF and TGF-b mRNAs were examined by RT-PCR ( Figure 6 ). IFN-g mRNA expression was observed 12, 24 and 48 h after the administration of baculovirus. Strong HGF expression was observed only 2 h after administration of the baculovirus, whereas TGF-b expression was reduced after 12 h. This finding suggests that HGF inhibits TGF-b expression. 45 HGF gene expression decreased after 12 h, and returned to untreated control levels after 48 h. These results indicate that IFNs and HGF are induced by baculovirus administration, and that these factors inhibit TGF-b, thereby alleviating hepatic fibrosis.
Discussion
In the present study, we established a mouse model of hepatic fibrosis using intraperitoneal administration of the mutagen DMN every second day for 3 weeks. Hepatic damage was monitored and confirmed by the presence of high serum levels of collagen and the transaminases ALT and ASL. Control saline administration did not alleviate the effects of DMN on the liver, as the collagen, ALT and ASL levels remained high. However, baculovirus administration significantly reduced the levels of collagen, ALT and ASL, although there was no significant difference between different baculovirus concentrations.
Collagen levels were measured to evaluate the effect of baculovirus on the hepatic accumulation of collagen, another indicator of DMN-induced hepatitis. Compared to saline administration, baculovirus administration significantly decreased the accumulation of collagen, although there were no statistical differences among different baculovirus concentrations. The improvement in the formation of collagen fibers induced by baculovirus administration was analyzed pathologically by MT staining. The expression of a-SMA was reduced in the activated stellate cells of mice that were administered with baculovirus. Although DMN-induced fiber formation in the sinusoid was not improved after the administration of saline, fibrosis was alleviated by the administration of baculovirus. Moreover, alleviation of fibrosis correlated with the level of collagen.
The examination of hepatic cells by HE staining revealed marked centrolobular vacuole degeneration after DMN administration, which was not improved by saline administration. However, baculovirus administration alleviated the degeneration in a dose-dependent manner.
During the progression of liver fibrosis, there is a marked increase in TIMPs, which leads to a net decrease in the catalytic activity of MMPs. Evaluation of the expression of these key molecules in the present study revealed that the steady-state level of mRNA transcripts for interstitial collagenase MMPs following administration of baculovirus was lower compared with that in saline-injected cirrhotic animals. Hepatic regeneration is an important component of the recovery process that occurs after various hepatic injuries. 46 Previous studies of liver regeneration following acute liver damage or partial hepatectomy demonstrated that the hepatic biomatrix contains large amounts of HGF, 47 predominantly around portal triads. 48 Matrix breakdown may cause rapid release of HGF, thus accounting for the rapid increase in HGF levels in the blood plasma. In the present study, HGF levels were increased in baculovirusadministered animals, correlating with increased HGF mRNA and protein expression. RT-PCR revealed strong HGF expression after only 2 h, and a reduction in the In conclusion, we have demonstrated that intraperitoneal inoculation with the baculovirus AcNPV alleviates hepatic fibrosis and improves hepatic damage in a mouse model of DMN-induced hepatic fibrosis. The present study, to our knowledge, is the first to provide evidence of the feasibility and advantages of using baculovirus to treat HCV-associated liver diseases.
Materials and methods
Purified wild-type AcMNPV
Wild-type baculovirus AcMNPV was purchased from BD Biosciences (San Diego, CA, USA). Sf-9 insect cells were cultured at 27 1C in Sf-900IISFM (Invitrogen Corp., Carlsbad, CA, USA) containing 10% fetal bovine serum and 100 mg ml À1 kanamycin sulfate. Purification of the baculovirus was performed as previously described. 12 The virus stocks were endotoxin free (o0.01 U ml À1 ), as determined by a Pyrodick endotoxin measurement kit (Seikagaku Co., Tokyo, Japan).
Experimental design
A total of 55 female 7-week-old BALB/c mice (Charles River, Tokyo, Japan) were housed in plastic cages with a wire mesh base providing isolation from a hygienic bed, and were exposed to a 12 h controlled light cycle. Experiments were performed in accordance with institutional ethical guidelines. Hepatic fibrosis was induced by intraperitoneal injections of 10 mg kg À1 DMN (Sigma, St Louis, MO, USA) dissolved in saline to obtain a 1% solution, which was administered on 3 consecutive days a week for 3 weeks.
After the DMN injections, five mice were killed to examine LC development. The remaining 50 mice received intraperitoneal injections of a single infusion of 200 ml saline (n ¼ 10), 10 3 PFU AcMNPV (n ¼ 10), 10 5 PFU AcMNPV (n ¼ 10), 10 7 PFU AcMNPV (n ¼ 10) or 75 mg LPS (n ¼ 10).
Body and liver weights were recorded (data not shown), and blood samples were obtained for routine ALT and AST determination.
PCR and analysis of amplified products
Total DNA was purified from various tissues, and the presence of AcMNPV (10 7 PFU) was detected by performing PCR amplification of the viral gene AcMNPV-vp39. The sequences of the specific primers were as follows: AcMNPV-vp39, 5
0 -TATGGCGCCGCG ACAAATGAGAGTT-3 0 (sense) and 5 0 -TTCGCCTGCAA CACCAGGCGCAGG-3 0 (antisense); glyceraldehyde-3-phosphate dehydrogenase (G3PDH), 5
0 -TCCACCACC CTGTTGCTGTA-3 0 (sense) and 5 0 -ACCACAGTCCAT GCCATCAC-3 0 (antisense). After RT, nest PCR was performed to test the RT efficiency. Nest PCR were all assembled in 10 ml, including 1 ml first round PCR products as template for second PCR, 0.2 ml, 0.02 mM sense primer, 0.2 ml, 0.02 mM antisense primer, 2 ml, 10 Â PCR buffer with deoxyribonucleotide triphosphate AmpliTaq Gold (Applied Biosystems Co. Ltd, Foster City, CA, USA), 0.1 ml AmpliTa Gold DNA polymerase (Applied Biosystems Co. Ltd) and MgCl 2 . The RT-PCR products were amplified using the following thermal cycle program: 95 1C for 10 min, 30 cycles of 94 1C for 1 min, X1C for Y min and 72 1C for 1 min, followed by 72 1C for 7 min. PCR products were electrophoresed on 1.5% agarose gels. The sequences of the specific primers were as follows: AcMNPV-vp39, 5
0 -GACTGCGCCGCCG CCCAGAGTAGCGTTAGG-3 0 (sense) and 5 0 -CTGCATT TTCGCGTCCATCGTGTCGTTCGA-3 0 (antisense).
Tissue preparation
Liver specimens were routinely fixed in 4% phosphatebuffered formaldehyde or methanol for 18-24 h and were then embedded in paraffin. Tissue sections (4 mm thickness) were stained with HE for routine examination or with MT for collagen visualization and morphometric analysis. For RNA extraction, one-half of the remaining liver was cut into 150 mg pieces, dipped in liquid nitrogen and stored at À80 1C until required. The remaining liver tissue was finely minced and homogenized in three volumes of ice-cold buffer (50 mmol l À1 Tris, 150 mmol l À1 KCl, 1 mmol l À1 ethylene diamine tetraacetic acid (pH 7.4)).
RT-PCR
Total RNA was isolated from 150 mg liver specimens using the Isogen reagent (Nippon Gene, Tokyo, Japan). RT-PCR was performed with 2 mg RNA and the Takara One-Step RNA PCR Kit (Takara Bio Inc., Shiga, Japan). As an internal control, human G3PDH mRNA was amplified simultaneously with primers G3PDH-F (nucleotides 230-254) and downstream G3PDH-R (nucleotides 422-466), generating a 0.5 kb product. The RT-PCR products were amplified using the following thermal cycle program: 42 1C for 60 min, 94 1C for 2 min, then 30 cycles of 94 1C for 1 min, T1C for 1 min and 72 1C for 1 min, followed by 72 1C for 10 min. PCR products were electrophoresed on 1.5% agarose gels.
Colorimetric measurement of collagen
Briefly, at least five 15 mm thick sections from three samples per animal were deparaffinized, placed in 0.5 M acetic acid and homogenized. After centrifugation, the supernatant was treated with Sircol Collagen Assay Kit Dye Reagent (Biocolor Ltd, Belfast, UK) according to the manufacturer's instructions. After washing with distilled water, both dyes were eluted using an alkali reagent. The absorbance obtained at 540 nm was determined to AcMNPV-mediated IFN alleviates LC in a murine model Y Nishibe et al calculate the amount of collagen in each section (expressed as mg total collagen per mg total protein).
Immunohistochemical examination
Immunohistochemical analysis was performed using an antibody against mouse a-SMA (GeneTex Inc., San Antonio, TX, USA).
MMPs and TIMP expression
Levels of MMP-13, MMP-2 and TIMP-1 expression were examined by RT-PCR as described above using the following primer sets: MMP-13, forward ( 
Statistical analysis
Survival of rats was determined by the Kaplan-Meier method and compared by the logrank test. The difference in experimental parameters and proliferation indices among the treatment groups was analyzed using the oneway analysis of variance test. For all tests, Po0.05 was considered significant.
